- Home
- IMA vs DMA Comparison
IMA vs DMA Comparison
Compare IMA & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- DMA
- Stock Information
- Founded
- IMA 2019
- DMA 2011
- Country
- IMA United States
- DMA United States
- Employees
- IMA N/A
- DMA N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- DMA Trusts Except Educational Religious and Charitable
- Sector
- IMA Health Care
- DMA Finance
- Exchange
- IMA Nasdaq
- DMA Nasdaq
- Market Cap
- IMA 92.2M
- DMA 78.8M
- IPO Year
- IMA N/A
- DMA N/A
- Fundamental
- Price
- IMA $8.11
- DMA $8.67
- Analyst Decision
- IMA Buy
- DMA
- Analyst Count
- IMA 1
- DMA 0
- Target Price
- IMA $30.00
- DMA N/A
- AVG Volume (30 Days)
- IMA 91.8K
- DMA 34.6K
- Earning Date
- IMA 11-15-2025
- DMA 01-01-0001
- Dividend Yield
- IMA N/A
- DMA 2.04%
- EPS Growth
- IMA N/A
- DMA N/A
- EPS
- IMA N/A
- DMA N/A
- Revenue
- IMA $4,300,000.00
- DMA N/A
- Revenue This Year
- IMA N/A
- DMA N/A
- Revenue Next Year
- IMA N/A
- DMA N/A
- P/E Ratio
- IMA N/A
- DMA N/A
- Revenue Growth
- IMA N/A
- DMA N/A
- 52 Week Low
- IMA $7.24
- DMA $4.78
- 52 Week High
- IMA $23.28
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- DMA 45.32
- Support Level
- IMA N/A
- DMA $8.59
- Resistance Level
- IMA N/A
- DMA $8.75
- Average True Range (ATR)
- IMA 0.00
- DMA 0.10
- MACD
- IMA 0.00
- DMA -0.01
- Stochastic Oscillator
- IMA 0.00
- DMA 17.92
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.